Cargando…
Elevated Expression of Programmed Death-1 and Programmed Death Ligand-1 Negatively Regulates Immune Response against Cervical Cancer Cells
The present study is to measure the expression of programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1), as well as its clinical significance in cervical cancer patients. Our results showed that different T cell subsets in patients with cervical cancer had high expression of PD-1, and DCs...
Autores principales: | Chen, Zhifang, Pang, Nannan, Du, Rong, Zhu, Yuejie, Fan, Lingling, Cai, Donghui, Ding, Yan, Ding, Jianbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046046/ https://www.ncbi.nlm.nih.gov/pubmed/27721577 http://dx.doi.org/10.1155/2016/6891482 |
Ejemplares similares
-
Role of Regulatory B Cells in the Progression of Cervical Cancer
por: Chen, Zhifang, et al.
Publicado: (2019) -
The Th17/Treg balance and the expression of related cytokines in Uygur cervical cancer patients
por: Chen, Zhifang, et al.
Publicado: (2013) -
Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma
por: Yu, Wei-Bo, et al.
Publicado: (2019) -
Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients
por: Zhang, Yan, et al.
Publicado: (2011) -
Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas
por: Yang, Min-Wei, et al.
Publicado: (2019)